Literature DB >> 1092700

Response of myogenic and fibrogenic cells to cytochalasin B and to colcemid. I. Light microscope observations.

J Croop, H Holtzer.   

Abstract

Cytochalasin B (CB) induces a biphasic retraction is some cell types. The rapid response that peaks in 30 min leads to the "dendritic" condition. Replicating myogenic and fibrogenic cells, as well as postmitotic myoblasts and myotubes, participate in this reaction. This is followed by a slower phase that requires 40 h for stabilization and leads to the fully "absorized" state. Only replicating myogenic and fibrogenic cells participate in this reaction. Postmitotic myoblasts and myotubes do not arborize but round up and float off into the medium. Pretreatment with Colcemid does not block the rapid response to CB, but does block arborization. CB-arborized cells exposed to Colcemid while in the presence of CB develop sufficient tension to pull themselves apart. If CB depolymerizes actin-like filaments, and if such filaments constitute the only contractile system in the cell, then it is difficult to visualize how cells in CB develop such tension. Colcemid induces twisting, birefringent bands in interphase- and metaphase-arrested myogenic and fibrogenic cells, and in postmitotic myotubes. Such bands are more evident when CB-arborized cells are removed from CB and allowed to relax in Colcemid. These birefringent bands assemble in the prescence of cycloheximide, and may constitute 20% of the volume of the cell.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1092700      PMCID: PMC2109433          DOI: 10.1083/jcb.65.2.271

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  35 in total

1.  The effect of colchicine on striated muscle in tissue culture.

Authors:  G C GODMAN
Journal:  Exp Cell Res       Date:  1955-06       Impact factor: 3.905

2.  The inhibition of phagocytosis and facilitation of exocytosis in rabbit polymorphonuclear leukocytes by cytochalasin B.

Authors:  P Davies; R I Fox; M Polyzonis; A C Allison; A D Haswell
Journal:  Lab Invest       Date:  1973-01       Impact factor: 5.662

3.  Inhibition of the transport of several hexoses in mammalian cells by cytochalasin B.

Authors:  S B Mizel; L Wilson
Journal:  J Biol Chem       Date:  1972-06-25       Impact factor: 5.157

4.  The phenotypic complexity of myogenic clones.

Authors:  J Abbott; J Schiltz; S Dienstman; H Holtzer
Journal:  Proc Natl Acad Sci U S A       Date:  1974-04       Impact factor: 11.205

5.  Cytochalasin-B: effects on cytokinesis, glycogen and 3 H-D-gluconse incorporation.

Authors:  J W Sanger; H Holtzer
Journal:  Am J Anat       Date:  1972-10

6.  The loss of phenotypic traits by differentiated cells in vitro. VII. Effects of 5-bromodeoxyuridine and prolonged culturing on fine structure of chondrocytes.

Authors:  H C Anderson; S Chacko; J Abbott; H Holtzer
Journal:  Am J Pathol       Date:  1970-08       Impact factor: 4.307

7.  An analysis of myogenesis in vitro using fluorescein-labeled antimyosin.

Authors:  K Okazaki; H Holtzer
Journal:  J Histochem Cytochem       Date:  1965 Nov-Dec       Impact factor: 2.479

8.  Effects of cytochalasins on mammalian cells.

Authors:  S B Carter
Journal:  Nature       Date:  1967-01-21       Impact factor: 49.962

9.  Effects of mitotic spindle inhibitors on neurotubules and neurofilaments in anterior horn cells.

Authors:  H Wisniewski; M L Shelanski; R D Terry
Journal:  J Cell Biol       Date:  1968-07       Impact factor: 10.539

10.  Cell motility by labile association of molecules. The nature of mitotic spindle fibers and their role in chromosome movement.

Authors:  S Inoué; H Sato
Journal:  J Gen Physiol       Date:  1967-07       Impact factor: 4.086

View more
  35 in total

1.  Cellular partitioning of beta-1 integrins and their phosphorylated forms is altered after transformation by Rous sarcoma virus or treatment with cytochalasin D.

Authors:  B Haimovich; B J Aneskievich; D Boettiger
Journal:  Cell Regul       Date:  1991-04

2.  Myofibrillar and cytoskeletal assembly in neonatal rat cardiac myocytes cultured on laminin and collagen.

Authors:  L L Hilenski; L Terracio; T K Borg
Journal:  Cell Tissue Res       Date:  1991-06       Impact factor: 5.249

3.  Investigation of the mechanism of retraction of the cell margin and rearward flow of nodules during mitotic cell rounding.

Authors:  L P Cramer; T J Mitchison
Journal:  Mol Biol Cell       Date:  1997-01       Impact factor: 4.138

4.  Effects of cesium on in vitro myoblast differentiation: an electron microscopic study.

Authors:  W Malorni; P L Indovina; G Arancia; S Meschini; M T Santini
Journal:  In Vitro Cell Dev Biol       Date:  1990-04

5.  Process formation in astrocytes: modulation of cytoskeletal proteins.

Authors:  J Padmanabhan; M L Shelanski
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

6.  Differences among 100-A filamentilament subunits from different cell types.

Authors:  G S Bennett; S A Fellini; J M Croop; J J Otto; J Bryan; H Holtzer
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

7.  Localization of bovine brain filament antibody on intermediate (100 A) filaments in guinea pig vascular endothelial cells and chick cardiac muscle cells.

Authors:  S H Blose; M L Shelanski; S Chacko
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

8.  Metalloendoprotease inhibitors that block fusion also prevent biochemical differentiation in L6 myoblasts.

Authors:  E Baldwin; C Kayalar
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

9.  Altered cell spreading in cytochalasin B: a possible role for intermediate filaments.

Authors:  A S Menko; Y Toyama; D Boettiger; H Holtzer
Journal:  Mol Cell Biol       Date:  1983-01       Impact factor: 4.272

10.  The response of chicken embryo dermal fibroblasts to cytochalasin B is altered by Rous sarcoma virus-induced cell transformation.

Authors:  A S Menko; J Croop; Y Toyama; H Holtzer; D Boettiger
Journal:  Mol Cell Biol       Date:  1982-03       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.